SCHEMBL21928129

SCHEMBL21928129

N#Cc1ccncc1-c1ccccc1-c1ccccc1N1c2ccccc2Sc2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 1/20 0.36
ACHE P22303 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
BCHE P06276 2/20 0.33
HPGD P15428 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
IDO1 P14902 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21921751 0.99 FNTA (0.40) FNTAFNTBSMN1; SMN2HTTCYP1A2
SCHEMBL21928514 0.91 PDE10A (0.39) FNTAFNTBSMN1; SMN2HTTCYP1A2
SCHEMBL21928130 0.90 UCHL1 (0.39) FNTAFNTBSMN1; SMN2HTTCYP1A2
SCHEMBL21927712 0.88 UCHL1 (0.39) FNTAFNTBSMN1; SMN2HTTCYP1A2
SCHEMBL21927904 0.87 GABRG2 (0.39) FNTAFNTBHTTATRCYP11B2
SCHEMBL21928208 0.85 GABRG2 (0.35) FNTAFNTBSMN1; SMN2HTTALDH1A1
SCHEMBL17952908 0.84 SMN1; SMN2 (0.42) SMN1; SMN2CYP1A2CYP3A4CYP2D6ACHE
SCHEMBL17954897 0.83 MAOA (0.40) FNTAFNTBSMN1; SMN2CYP1A2ACHE
SCHEMBL21927228 0.83 ATR (0.36) HTTCYP1A2CYP3A4NCOA3ALDH1A1
SCHEMBL21928515 0.82 PDE10A (0.38) FNTAFNTBSMN1; SMN2HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CCNT1, CCNA1, CCNE2 FNTA 3461/4885FNTB 3879/4885SMN1; SMN2 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.